In detail, in the Oncomine database, MTFR2 was highly expressed in breast cancer, colorectal cancer, gastric cancer, lung cancer and other tumor tissues, while lowly- expressed in brain nerve tumor, breast cancer, leukemia and other tumor tissues (Fig. 1A). Here, MTFR2 is linked to colorectal cancer.